In direct ELISAs, approximately 25% cross-reactivity with recombinant human (rh) BMP-6 is observed and no cross-reactivity with rhBMP-2, -3, -4, -5, or -8 is observed. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method. The bone morphog